The Latest Cardiac and Vascular News
New metal-alloy scoring sheath CE Mark cleared for treatment of peripheral artery disease and end stage renal disease. PARK CITY, Utah, May 10, 2021 /PRNewswire/ — Transit Scientific announced it received CE Mark clearance in the European Union for the XO Score® Scoring Sheath Platform to facilitate dilation of stenotic material in the peripheral vasculature […]
BE’ER SHEVA, Israel, and SHENZHEN, China , May 10, 2021 /PRNewswire/ — DiA Imaging Analysis Ltd. (DiA), a leading provider of AI-powered ultrasound analysis solutions today announced that it has partnered with SonoScape Medical Corporation (300633.SZ), a leading developer and manufacturer of ultrasound systems. As part of the partnership, SonoScape’s ultrasound devices will provide DiA’s ultrasound artificial intelligence analysis solutions […]
VANCOUVER and MINNEAPOLIS, May 10, 2021 (GLOBE NEWSWIRE) — via NewMediaWire ‒ Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today announced that the first patient has been enrolled in the COronary SInus Reducer for the Treatment of Refractory Microvascular Angina (“COSIMA”) trial. The enrollment occurred at University Hospital, Mainz, Germany. The patient is an 82-year-old woman who […]
ST. LOUIS, May 10, 2021 (GLOBE NEWSWIRE) — Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today reported financial results for the first quarter ended March 31, 2021. “The highlight of the first quarter is Stereotaxis’ return to robust double digit revenue growth with […]
MORRISVILLE, N.C., May 10, 2021 (GLOBE NEWSWIRE) — Liquidia Corporation (NASDAQ: LQDA) announced today that on May 7, 2021, it resubmitted its New Drug Application (NDA) for LIQ861 for the treatment of pulmonary arterial hypertension (PAH). The U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) regarding […]
Peer-reviewed publication in the Journal of the American Heart Association found the AI algorithm detects clinically significant murmurs comparable to expert cardiologists OAKLAND, Calif., May 10, 2021 (GLOBE NEWSWIRE) — Eko, a cardiopulmonary digital health company, today announced the peer-reviewed publication of a clinical study that found that the Eko artificial intelligence (AI) […]
– Enrollment continues in second cohort of EnACT study of MAT2203 (oral amphotericin b) in cryptococcal meningitis; Data and Safety Monitoring Board (DSMB) evaluation of safety and efficacy data from second cohort anticipated Q3 2021 – – MAT2501 (oral amikacin) advanced into preclinical toxicology and efficacy studies; completion of Phase […]
NEW YORK–(BUSINESS WIRE)–Heartbeat Health, a healthcare company working to deliver the most effective, efficient, and engaging heart care, announced today that it has raised $20 million in Series B funding, led by Echo Health Ventures, with participation from DaVita Venture Group and existing investors, .406 Ventures, Optum Ventures, Kindred Ventures, […]
Industry Veterans Join Executive Leadership Team to Empower Next Stage of Company Growth BOSTON–(BUSINESS WIRE)–Elucid, a medical technology company developing AI software to enable cardiovascular disease detection, today announced $8 Million in Series A financing led by MedTex Ventures and Global Health Impact Fund. New and existing investors Checkmate Capital, […]
In this episode of Investor Insights, Ken Dropiewski sits down with Jason Lettmann about Lightstone ventures and the MedTech/Life Science industry including Colorado.
